Cytori Therapeutics to Present at the LD Micro Conference on December 5
LD MICRO 2013
SAN DIEGO -- December 3, 2013
Cytori Therapeutics Inc. (NASDAQ: CYTX) will present and provide a corporate
update from the LD Micro Conference on Thursday, December 5, at 4:30 PM PT.
The presentation will be webcast and may be accessed under “Webcasts” under
Cytori’s Investor Relations section of the website. The webcast can be viewed
live and will be available for replay after the presentation on the Company’s
Cytori Therapeutics is developing cell therapies based on autologous
adipose-derived regenerative cells (ADRCs) to treat cardiovascular disease and
other medical conditions. Our scientific data suggest ADRCs improve blood
flow, moderate the inflammatory response and keep tissue at risk of dying
alive. As a result, we believe these cells can be applied across multiple
“ischemic” conditions. These therapies are made available to the physician and
patient at the point-of-care by Cytori’s proprietary technologies and
products, including the Celution System product family. www.cytori.com
Cytori Therapeutics Inc.
Megan McCormick, +1-858-875-5279
Press spacebar to pause and continue. Press esc to stop.